抜粋
For a long time it has been known that obesity (adiposity) is linked to insulin resistance. Recently, many investigators have reported that adipocytes secrete a variety of bioactive molecules, termed adipokines (adipocytokines), including TNFα, IL-6, leptin, adiponectin, resistin and so on. These adipokines play pivotal roles in energy homeostasis by affecting insulin sensitivity, glucose and lipid metabolisms, food intake, the coagulation system and inflammation. This review provides a summary of these adipose tissue-secreting biomolecules and discusses their feasibilities as drug targets for the treatment of metabolic syndrome.
| 元の言語 | 英語 |
|---|---|
| ページ（範囲） | 525-529 |
| ページ数 | 5 |
| ジャーナル | Current Drug Targets |
| 巻 | 6 |
| 発行部数 | 4 |
| DOI | |
| 出版物ステータス | 出版済み - 6 2005 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Pharmacology
- Drug Discovery
- Clinical Biochemistry
フィンガープリント Adipokines: Therapeutic targets for metabolic syndrome' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。
これを引用
Kobayashi, K., & Inoguchi, T. (2005). Adipokines: Therapeutic targets for metabolic syndrome. Current Drug Targets, 6(4), 525-529. https://doi.org/10.2174/1389450054021972